HSA — authorised 4 August 2023
- Marketing authorisation holder: SAGE THERAP
- Status: likely_approved
HSA authorised Zurzuvae on 4 August 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 4 August 2023.
SAGE THERAP holds the Singaporean marketing authorisation.